Schedule 13G ownership disclosure
AngioSoma, Inc.
Security class unavailable · CUSIP: 03476L102
Event date: 2016-06-22
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 10,000,000
- Percent of class
- 33.3100%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001161697-16-000943
- Form type
- SC 13G
- Filer
- GlobeStar Therapeutics Corp
- CIK
- CIK 1502152
- Filed
- Jun 28, 2016
- Reporting period
- Jun 22, 2016
- Description
- Schedule 13G beneficial ownership